Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie J Miller

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 27, 2022
Targeting IDH-Mutant GliomaJulie J Miller
Current Neurology and Neuroscience Reports|May 24, 2020
Lower Grade GliomasGilbert Youssef, Julie J Miller
Seminars in Neurology|March 17, 2018
What's New in Grade II and Grade III Gliomas?Julie J Miller, Wolfgang Wick
Expert Opinion on Emerging Drugs|November 5, 2016
Emerging targeted therapies for gliomaJulie J Miller, Patrick Y Wen
Seminars in Neurology|November 5, 2014
Neuro-Behçet disease and autoinflammatory disordersJulie J Miller, Nagagopal Venna, Aksel Siva
Proteomics|May 1, 2009
High-throughput generation of tagged stable cell lines for proteomic analysisJorge Z Torres, Julie J Miller, Peter K Jackson
Cancer|December 28, 2016
Diagnosis and treatment of epidural metastasesM Loreto Yáñez, Julie J Miller, Tracy T Batchelor
Cancer|October 6, 2017
Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implicationsJulie J Miller, Helen A Shih, Ovidiu C Andronesi, et al.
Neuro-Oncology Practice|October 13, 2025
A single-institution study of the natural history of fibroblast growth factor receptor-altered gliomasMaya Viera, Christopher W Mount, Dora Dias-Santagata, et al.
Neurosurgical Focus|February 1, 2022
Implications of IDH mutations on immunotherapeutic strategies for malignant gliomaLeland G Richardson, Julie J Miller, Yosuke Kitagawa, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 27, 2022
Targeting IDH-Mutant GliomaJulie J Miller
Current Neurology and Neuroscience Reports|May 24, 2020
Lower Grade GliomasGilbert Youssef, Julie J Miller
Seminars in Neurology|March 17, 2018
What's New in Grade II and Grade III Gliomas?Julie J Miller, Wolfgang Wick
Expert Opinion on Emerging Drugs|November 5, 2016
Emerging targeted therapies for gliomaJulie J Miller, Patrick Y Wen
Seminars in Neurology|November 5, 2014
Neuro-Behçet disease and autoinflammatory disordersJulie J Miller, Nagagopal Venna, Aksel Siva
Proteomics|May 1, 2009
High-throughput generation of tagged stable cell lines for proteomic analysisJorge Z Torres, Julie J Miller, Peter K Jackson
Cancer|December 28, 2016
Diagnosis and treatment of epidural metastasesM Loreto Yáñez, Julie J Miller, Tracy T Batchelor
Cancer|October 6, 2017
Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implicationsJulie J Miller, Helen A Shih, Ovidiu C Andronesi, et al.
Neuro-Oncology Practice|October 13, 2025
A single-institution study of the natural history of fibroblast growth factor receptor-altered gliomasMaya Viera, Christopher W Mount, Dora Dias-Santagata, et al.
Neurosurgical Focus|February 1, 2022
Implications of IDH mutations on immunotherapeutic strategies for malignant gliomaLeland G Richardson, Julie J Miller, Yosuke Kitagawa, et al.
Pageof 6